Literature DB >> 31140421

[Mig-7 gene silencing inhibits vasculogenic mimicry formation and invasion of glioma U251 cells in vitro by suppressing MEK/ERK signaling].

Fan Wang1, Fenglong Chen1, Weipeng Hu2, Yi Zhang1.   

Abstract

OBJECTIVE: To investigate the inhibitory effects of silencing migration-inducing gene-7 (Mig-7) on vasculogenic mimicry formation, migration and invasion of human glioma cells in vitro and whether MEK/ERK signaling pathway mediates these effects.
METHODS: Human glioma U251 cells were infected by lentiviral vectors carrying a small interfering RNA targeting Mig-7 gene (sh-Mig-7) or a negative control shRNA (sh-NC), and real-time quantitative PCR was used to detect the expression level of Mig-7 mRNA in the cells. Three-dimensional culture and Transwell chamber invasion assay were used to observe the effect of Mig-7 gene silencing on vasculogenic mimicry formation and invasion ability of the U251 cells. Western blotting was performed to detect the changes in the protein expression levels of MEK/ERK in the infected cells.
RESULTS: We successfully obtained a U251 cell line with stable low expression of Mig-7 gene using RNA interference technique. Compared with the cells infected with sh-NC lentivirus and the non- infected cells, U251 cells infected with the lentiviral vector carrying sh-Mig-7 showed significantly decreased expression level of Mig-7 (P < 0.01) with obviously lowered vasculogenic mimicry formation and invasion abilities (P < 0.05). Mig-7 silencing also significantly lowered the expressions of MEK and ERK proteins in U251 cells (P < 0.05).
CONCLUSIONS: Silencing of Mig-7 gene inhibits vasculogenic mimicry formation and invasion of U251 cells possibly by suppressing MEK/ERK signaling, suggesting the important role of Mig-7 gene in vasculogenic mimicry formation and invasion of human glioma cells.

Entities:  

Keywords:  Mig-7; RNA interference; glioma; tumor invasion; vasculogenic mimicry

Mesh:

Substances:

Year:  2019        PMID: 31140421      PMCID: PMC6743935          DOI: 10.12122/j.issn.1673-4254.2019.05.11

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  22 in total

1.  Silencing the autophagy-specific gene Beclin-1 contributes to attenuated hypoxia-induced vasculogenic mimicry formation in glioma.

Authors:  Shujie Duan
Journal:  Cancer Biomark       Date:  2018-02-14       Impact factor: 4.388

2.  Dynamic regulation of VEGF-inducible genes by an ERK/ERG/p300 transcriptional network.

Authors:  Jason E Fish; Manuel Cantu Gutierrez; Lan T Dang; Nadiya Khyzha; Zhiqi Chen; Shawn Veitch; Henry S Cheng; Melvin Khor; Lina Antounians; Makon-Sébastien Njock; Emilie Boudreau; Alexander M Herman; Alexander M Rhyner; Oscar E Ruiz; George T Eisenhoffer; Alejandra Medina-Rivera; Michael D Wilson; Joshua D Wythe
Journal:  Development       Date:  2017-05-23       Impact factor: 6.868

3.  N-cadherin participated in invasion and metastasis of human esophageal squamous cell carcinoma via taking part in the formation of vasculogenic mimicry.

Authors:  Feng Wang; Xiang-Ke Li; Hong-Yan Xu; Zheng-Zheng Shan; Tao Wang; Zi-Chang Yang; Wei He; Liu-Xing Wang; Qing-Xia Fan
Journal:  Med Oncol       Date:  2015-01-10       Impact factor: 3.064

4.  Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.

Authors:  Caroline I Schnegg; Moon Hee Yang; Subrata K Ghosh; Mei-Yu Hsu
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

5.  [Future targeting of the RAS/RAF/MEK/ERK signaling pathway in oncology: the example of melanoma].

Authors:  Gilles Favre
Journal:  Bull Acad Natl Med       Date:  2014-02       Impact factor: 0.144

6.  The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.

Authors:  Dongsic Choi; Laura Montermini; Dae-Kyum Kim; Brian Meehan; Frederick P Roth; Janusz Rak
Journal:  Mol Cell Proteomics       Date:  2018-07-13       Impact factor: 5.911

7.  Mig-7 expression and vasculogenic mimicry in malignant ovarian tumors.

Authors:  Artur Czekierdowski; Sylwia Czekierdowska; Norbert Stachowicz; Tomasz Łoziński; Grzegorz Gurynowicz
Journal:  Ginekol Pol       Date:  2017       Impact factor: 1.232

8.  The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC.

Authors:  Lei Li; Guo-Dong Zhao; Zhe Shi; Li-Li Qi; Li-Yuan Zhou; Ze-Xian Fu
Journal:  Oncol Lett       Date:  2016-09-09       Impact factor: 2.967

9.  Correlation Between Raf/MEK/ERK Signaling Pathway and Clinicopathological Features and Prognosis for Patients With Breast Cancer Having Axillary Lymph Node Metastasis.

Authors:  Guo-Li Shao; Meng-Chuan Wang; Xu-Long Fan; Lin Zhong; Shu-Feng Ji; Guo Sang; Shui Wang
Journal:  Technol Cancer Res Treat       Date:  2018-01-01

Review 10.  Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance.

Authors:  James A McCubrey; Linda S Steelman; William H Chappell; Stephen L Abrams; Richard A Franklin; Giuseppe Montalto; Melchiorre Cervello; Massimo Libra; Saverio Candido; Grazia Malaponte; Maria C Mazzarino; Paolo Fagone; Ferdinando Nicoletti; Jörg Bäsecke; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Michele Milella; Agostino Tafuri; Francesca Chiarini; Camilla Evangelisti; Lucio Cocco; Alberto M Martelli
Journal:  Oncotarget       Date:  2012-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.